210 related articles for article (PubMed ID: 35654215)
1. Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases.
Gao X; Xu J; Yao T; Liu X; Zhang H; Zhan C
Adv Drug Deliv Rev; 2022 Aug; 187():114362. PubMed ID: 35654215
[TBL] [Abstract][Full Text] [Related]
2. Ligand-Appended BBB-Targeted Nanocarriers (LABTNs).
Jain A; Jain SK
Crit Rev Ther Drug Carrier Syst; 2015; 32(2):149-80. PubMed ID: 25955883
[TBL] [Abstract][Full Text] [Related]
3. Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation.
May JN; Golombek SK; Baues M; Dasgupta A; Drude N; Rix A; Rommel D; von Stillfried S; Appold L; Pola R; Pechar M; van Bloois L; Storm G; Kuehne AJC; Gremse F; Theek B; Kiessling F; Lammers T
Theranostics; 2020; 10(4):1948-1959. PubMed ID: 32042346
[No Abstract] [Full Text] [Related]
4. Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.
Mulvihill JJ; Cunnane EM; Ross AM; Duskey JT; Tosi G; Grabrucker AM
Nanomedicine (Lond); 2020 Jan; 15(2):205-214. PubMed ID: 31916480
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles.
Poustforoosh A; Nematollahi MH; Hashemipour H; Pardakhty A
J Control Release; 2022 Mar; 343():777-797. PubMed ID: 35183653
[TBL] [Abstract][Full Text] [Related]
6. [Research progress on liposome and nanomicelle targeted drug delivery system across blood-brain barrier].
Yang X; Zou LH; Ding WY; Zhang ZB; Chen JQ; Li JL; Feng HL; Li YY; Tang L; Feng JF
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(22):5965-5977. PubMed ID: 36471922
[TBL] [Abstract][Full Text] [Related]
7. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
8. Targeted transport of nanocarriers into brain for theranosis with rabies virus glycoprotein-derived peptide.
Fu C; Xiang Y; Li X; Fu A
Mater Sci Eng C Mater Biol Appl; 2018 Jun; 87():155-166. PubMed ID: 29549945
[TBL] [Abstract][Full Text] [Related]
9. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
10. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
[TBL] [Abstract][Full Text] [Related]
11. Getting into the brain: approaches to enhance brain drug delivery.
Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
[TBL] [Abstract][Full Text] [Related]
12. Brain drug targeting and gene technologies.
Pardridge WM
Jpn J Pharmacol; 2001 Oct; 87(2):97-103. PubMed ID: 11700018
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-mediated strategies in opening brain barriers for drug brain delivery.
Zhao YZ; Lu CT; Li XK; Cai J
Expert Opin Drug Deliv; 2013 Jul; 10(7):987-1001. PubMed ID: 23550691
[TBL] [Abstract][Full Text] [Related]
14. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
15. Designing peptide nanoparticles for efficient brain delivery.
Duro-Castano A; Moreira Leite D; Forth J; Deng Y; Matias D; Noble Jesus C; Battaglia G
Adv Drug Deliv Rev; 2020; 160():52-77. PubMed ID: 33031897
[TBL] [Abstract][Full Text] [Related]
16. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
[TBL] [Abstract][Full Text] [Related]
17. A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice.
Guo Q; Xu S; Yang P; Wang P; Lu S; Sheng D; Qian K; Cao J; Lu W; Zhang Q
J Control Release; 2020 Apr; 320():347-362. PubMed ID: 31978446
[TBL] [Abstract][Full Text] [Related]
18. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption.
Al-Ahmady ZS
Expert Opin Drug Deliv; 2018 Apr; 15(4):335-349. PubMed ID: 29466890
[TBL] [Abstract][Full Text] [Related]
19. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
Zhou X; Smith QR; Liu X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
[TBL] [Abstract][Full Text] [Related]
20. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
Gabathuler R
Neurobiol Dis; 2010 Jan; 37(1):48-57. PubMed ID: 19664710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
